Global and Asia Animal Pharmaceutical Market

Animal Pharmaceutical Comprehensive Study by Type (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Others), Application (Companion Animal, Poultry, Other), Disease (Orthopedic Diseases, Infectious Diseases, Dermatological Diseases, Behavioral Disorders, Pain, Dental Diseases, Others), Distribution Channel (Retail, E-commerce, Hospitals & Clinics), Animal (Cats, Dogs, Horses, Others) Players and Region - Global Market Outlook to 2028

Animal Pharmaceutical Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Animal Pharmaceutical Market Overview:
The animal pharmaceutical market is expected to witness significant growth over the forecast period owing to growing incidences of zoonotic diseases caused by climate change, increasing healthcare infrastructure, pet ownership and technological development in genomics and biotech. Further, increasing demand from the developing economies and rising government initiatives to promote animal healthcare products expected to drive the demand for animal pharmaceutical market over the forecasted period.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Increasing Pet Ownership and Increasing concern about pet health and welfare

Market Growth Drivers:
Increasing prevalence of zoonotic diseases, Rising veterinary Healthcare expenditure and Government initiatives to promote Animal Healthcare products

Restraints:
The Rising Cost of Animal Pharmaceuticals and Stringent Government Regulation

Opportunities:
Technological Development in Genomics and Biotech and Increasing Need of Advanced vaccines and pharmaceuticals

Competitive Landscape:

Some of the key players profiled in the report are Zoetis, Inc. (United States), Bayer AG (Germany), Boehringer Ingelheim GmbH (Germany), Eli Lilly and Company (United States), Merck & Co., Inc. (United States), Vetoquinol (France), Virbac (France), Ceva Sante Animale (France), Aratana Therapeutics, Inc. (United States) and Other. Additionally, following companies can also be profiled that are part of our coverage like Dechra Pharmaceuticals plc (United Kingdom). Analyst at AMA Research see United States Players to retain maximum share of Global Animal Pharmaceutical market by 2028. Considering Market by Disease, the sub-segment i.e. Orthopedic Diseases will boost the Animal Pharmaceutical market. Considering Market by Distribution Channel, the sub-segment i.e. Retail will boost the Animal Pharmaceutical market. Considering Market by Animal, the sub-segment i.e. Cats will boost the Animal Pharmaceutical market.

What Can be Explored with the Animal Pharmaceutical Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Animal Pharmaceutical Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Animal Pharmaceutical
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Animal Pharmaceutical market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Animal Pharmaceutical market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Healthcare Organizations, Veterinary Hospitals & Clinics, Point-of-care Testing/In-house Testing Centers, Reference Laboratories, Industry Associations, Research Organizations and Consulting Companies, Organizations, Associations and Alliances, Government Bodies Such As Regulating Authorities and Policy Makers., Market Research and Consulting Firms and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Vaccines
  • Pharmaceuticals
  • Feed Additives
  • Diagnostics
  • Others
By Application
  • Companion Animal
  • Poultry
  • Other
By Disease
  • Orthopedic Diseases
  • Infectious Diseases
  • Dermatological Diseases
  • Behavioral Disorders
  • Pain
  • Dental Diseases
  • Others

By Distribution Channel
  • Retail
  • E-commerce
  • Hospitals & Clinics

By Animal
  • Cats
  • Dogs
  • Horses
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of zoonotic diseases
      • 3.2.2. Rising veterinary Healthcare expenditure
      • 3.2.3. Government initiatives to promote Animal Healthcare products
    • 3.3. Market Trends
      • 3.3.1. Increasing Pet Ownership
      • 3.3.2. Increasing concern about pet health and welfare
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Pharmaceutical, by Type, Application, Disease, Distribution Channel, Animal and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Animal Pharmaceutical (Value)
      • 5.2.1. Global Animal Pharmaceutical by: Type (Value)
        • 5.2.1.1. Vaccines
        • 5.2.1.2. Pharmaceuticals
        • 5.2.1.3. Feed Additives
        • 5.2.1.4. Diagnostics
        • 5.2.1.5. Others
      • 5.2.2. Global Animal Pharmaceutical by: Application (Value)
        • 5.2.2.1. Companion Animal
        • 5.2.2.2. Poultry
        • 5.2.2.3. Other
      • 5.2.3. Global Animal Pharmaceutical by: Disease (Value)
        • 5.2.3.1. Orthopedic Diseases
        • 5.2.3.2. Infectious Diseases
        • 5.2.3.3. Dermatological Diseases
        • 5.2.3.4. Behavioral Disorders
        • 5.2.3.5. Pain
        • 5.2.3.6. Dental Diseases
        • 5.2.3.7. Others
      • 5.2.4. Global Animal Pharmaceutical by: Distribution Channel (Value)
        • 5.2.4.1. Retail
        • 5.2.4.2. E-commerce
        • 5.2.4.3. Hospitals & Clinics
      • 5.2.5. Global Animal Pharmaceutical by: Animal (Value)
        • 5.2.5.1. Cats
        • 5.2.5.2. Dogs
        • 5.2.5.3. Horses
        • 5.2.5.4. Others
      • 5.2.6. Global Animal Pharmaceutical Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Animal Pharmaceutical (Price)
      • 5.3.1. Global Animal Pharmaceutical by: Type (Price)
  • 6. Animal Pharmaceutical: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boehringer Ingelheim GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Eli Lilly and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck & Co., Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Vetoquinol (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Virbac (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ceva Sante Animale (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Aratana Therapeutics, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Other
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Animal Pharmaceutical Sale, by Type, Application, Disease, Distribution Channel, Animal and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Animal Pharmaceutical (Value)
      • 7.2.1. Global Animal Pharmaceutical by: Type (Value)
        • 7.2.1.1. Vaccines
        • 7.2.1.2. Pharmaceuticals
        • 7.2.1.3. Feed Additives
        • 7.2.1.4. Diagnostics
        • 7.2.1.5. Others
      • 7.2.2. Global Animal Pharmaceutical by: Application (Value)
        • 7.2.2.1. Companion Animal
        • 7.2.2.2. Poultry
        • 7.2.2.3. Other
      • 7.2.3. Global Animal Pharmaceutical by: Disease (Value)
        • 7.2.3.1. Orthopedic Diseases
        • 7.2.3.2. Infectious Diseases
        • 7.2.3.3. Dermatological Diseases
        • 7.2.3.4. Behavioral Disorders
        • 7.2.3.5. Pain
        • 7.2.3.6. Dental Diseases
        • 7.2.3.7. Others
      • 7.2.4. Global Animal Pharmaceutical by: Distribution Channel (Value)
        • 7.2.4.1. Retail
        • 7.2.4.2. E-commerce
        • 7.2.4.3. Hospitals & Clinics
      • 7.2.5. Global Animal Pharmaceutical by: Animal (Value)
        • 7.2.5.1. Cats
        • 7.2.5.2. Dogs
        • 7.2.5.3. Horses
        • 7.2.5.4. Others
      • 7.2.6. Global Animal Pharmaceutical Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Animal Pharmaceutical (Price)
      • 7.3.1. Global Animal Pharmaceutical by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Pharmaceutical: by Type(USD Million)
  • Table 2. Animal Pharmaceutical Vaccines , by Region USD Million (2017-2022)
  • Table 3. Animal Pharmaceutical Pharmaceuticals , by Region USD Million (2017-2022)
  • Table 4. Animal Pharmaceutical Feed Additives , by Region USD Million (2017-2022)
  • Table 5. Animal Pharmaceutical Diagnostics , by Region USD Million (2017-2022)
  • Table 6. Animal Pharmaceutical Others , by Region USD Million (2017-2022)
  • Table 7. Animal Pharmaceutical: by Application(USD Million)
  • Table 8. Animal Pharmaceutical Companion Animal , by Region USD Million (2017-2022)
  • Table 9. Animal Pharmaceutical Poultry , by Region USD Million (2017-2022)
  • Table 10. Animal Pharmaceutical Other , by Region USD Million (2017-2022)
  • Table 11. Animal Pharmaceutical: by Disease(USD Million)
  • Table 12. Animal Pharmaceutical Orthopedic Diseases , by Region USD Million (2017-2022)
  • Table 13. Animal Pharmaceutical Infectious Diseases , by Region USD Million (2017-2022)
  • Table 14. Animal Pharmaceutical Dermatological Diseases , by Region USD Million (2017-2022)
  • Table 15. Animal Pharmaceutical Behavioral Disorders , by Region USD Million (2017-2022)
  • Table 16. Animal Pharmaceutical Pain , by Region USD Million (2017-2022)
  • Table 17. Animal Pharmaceutical Dental Diseases , by Region USD Million (2017-2022)
  • Table 18. Animal Pharmaceutical Others , by Region USD Million (2017-2022)
  • Table 19. Animal Pharmaceutical: by Distribution Channel(USD Million)
  • Table 20. Animal Pharmaceutical Retail , by Region USD Million (2017-2022)
  • Table 21. Animal Pharmaceutical E-commerce , by Region USD Million (2017-2022)
  • Table 22. Animal Pharmaceutical Hospitals & Clinics , by Region USD Million (2017-2022)
  • Table 23. Animal Pharmaceutical: by Animal(USD Million)
  • Table 24. Animal Pharmaceutical Cats , by Region USD Million (2017-2022)
  • Table 25. Animal Pharmaceutical Dogs , by Region USD Million (2017-2022)
  • Table 26. Animal Pharmaceutical Horses , by Region USD Million (2017-2022)
  • Table 27. Animal Pharmaceutical Others , by Region USD Million (2017-2022)
  • Table 28. South America Animal Pharmaceutical, by Country USD Million (2017-2022)
  • Table 29. South America Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 30. South America Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 31. South America Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 32. South America Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 33. South America Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 34. Brazil Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 35. Brazil Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 36. Brazil Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 37. Brazil Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 38. Brazil Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 39. Argentina Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 40. Argentina Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 41. Argentina Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 42. Argentina Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 43. Argentina Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 44. Rest of South America Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 45. Rest of South America Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 46. Rest of South America Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 47. Rest of South America Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 48. Rest of South America Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 49. Asia Pacific Animal Pharmaceutical, by Country USD Million (2017-2022)
  • Table 50. Asia Pacific Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 51. Asia Pacific Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 52. Asia Pacific Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 53. Asia Pacific Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 54. Asia Pacific Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 55. China Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 56. China Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 57. China Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 58. China Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 59. China Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 60. Japan Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 61. Japan Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 62. Japan Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 63. Japan Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 64. Japan Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 65. India Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 66. India Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 67. India Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 68. India Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 69. India Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 70. South Korea Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 71. South Korea Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 72. South Korea Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 73. South Korea Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 74. South Korea Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 75. Taiwan Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 76. Taiwan Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 77. Taiwan Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 78. Taiwan Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 79. Taiwan Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 80. Australia Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 81. Australia Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 82. Australia Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 83. Australia Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 84. Australia Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 85. Rest of Asia-Pacific Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 86. Rest of Asia-Pacific Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 87. Rest of Asia-Pacific Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 88. Rest of Asia-Pacific Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 89. Rest of Asia-Pacific Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 90. Europe Animal Pharmaceutical, by Country USD Million (2017-2022)
  • Table 91. Europe Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 92. Europe Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 93. Europe Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 94. Europe Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 95. Europe Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 96. Germany Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 97. Germany Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 98. Germany Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 99. Germany Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 100. Germany Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 101. France Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 102. France Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 103. France Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 104. France Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 105. France Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 106. Italy Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 107. Italy Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 108. Italy Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 109. Italy Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 110. Italy Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 111. United Kingdom Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 112. United Kingdom Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 113. United Kingdom Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 114. United Kingdom Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 115. United Kingdom Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 116. Netherlands Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 117. Netherlands Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 118. Netherlands Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 119. Netherlands Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 120. Netherlands Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 121. Rest of Europe Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 122. Rest of Europe Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 123. Rest of Europe Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 124. Rest of Europe Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 125. Rest of Europe Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 126. MEA Animal Pharmaceutical, by Country USD Million (2017-2022)
  • Table 127. MEA Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 128. MEA Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 129. MEA Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 130. MEA Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 131. MEA Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 132. Middle East Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 133. Middle East Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 134. Middle East Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 135. Middle East Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 136. Middle East Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 137. Africa Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 138. Africa Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 139. Africa Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 140. Africa Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 141. Africa Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 142. North America Animal Pharmaceutical, by Country USD Million (2017-2022)
  • Table 143. North America Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 144. North America Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 145. North America Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 146. North America Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 147. North America Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 148. United States Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 149. United States Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 150. United States Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 151. United States Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 152. United States Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 153. Canada Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 154. Canada Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 155. Canada Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 156. Canada Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 157. Canada Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 158. Mexico Animal Pharmaceutical, by Type USD Million (2017-2022)
  • Table 159. Mexico Animal Pharmaceutical, by Application USD Million (2017-2022)
  • Table 160. Mexico Animal Pharmaceutical, by Disease USD Million (2017-2022)
  • Table 161. Mexico Animal Pharmaceutical, by Distribution Channel USD Million (2017-2022)
  • Table 162. Mexico Animal Pharmaceutical, by Animal USD Million (2017-2022)
  • Table 163. Animal Pharmaceutical: by Type(USD/Units)
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Company Basic Information, Sales Area and Its Competitors
  • Table 174. Animal Pharmaceutical: by Type(USD Million)
  • Table 175. Animal Pharmaceutical Vaccines , by Region USD Million (2023-2028)
  • Table 176. Animal Pharmaceutical Pharmaceuticals , by Region USD Million (2023-2028)
  • Table 177. Animal Pharmaceutical Feed Additives , by Region USD Million (2023-2028)
  • Table 178. Animal Pharmaceutical Diagnostics , by Region USD Million (2023-2028)
  • Table 179. Animal Pharmaceutical Others , by Region USD Million (2023-2028)
  • Table 180. Animal Pharmaceutical: by Application(USD Million)
  • Table 181. Animal Pharmaceutical Companion Animal , by Region USD Million (2023-2028)
  • Table 182. Animal Pharmaceutical Poultry , by Region USD Million (2023-2028)
  • Table 183. Animal Pharmaceutical Other , by Region USD Million (2023-2028)
  • Table 184. Animal Pharmaceutical: by Disease(USD Million)
  • Table 185. Animal Pharmaceutical Orthopedic Diseases , by Region USD Million (2023-2028)
  • Table 186. Animal Pharmaceutical Infectious Diseases , by Region USD Million (2023-2028)
  • Table 187. Animal Pharmaceutical Dermatological Diseases , by Region USD Million (2023-2028)
  • Table 188. Animal Pharmaceutical Behavioral Disorders , by Region USD Million (2023-2028)
  • Table 189. Animal Pharmaceutical Pain , by Region USD Million (2023-2028)
  • Table 190. Animal Pharmaceutical Dental Diseases , by Region USD Million (2023-2028)
  • Table 191. Animal Pharmaceutical Others , by Region USD Million (2023-2028)
  • Table 192. Animal Pharmaceutical: by Distribution Channel(USD Million)
  • Table 193. Animal Pharmaceutical Retail , by Region USD Million (2023-2028)
  • Table 194. Animal Pharmaceutical E-commerce , by Region USD Million (2023-2028)
  • Table 195. Animal Pharmaceutical Hospitals & Clinics , by Region USD Million (2023-2028)
  • Table 196. Animal Pharmaceutical: by Animal(USD Million)
  • Table 197. Animal Pharmaceutical Cats , by Region USD Million (2023-2028)
  • Table 198. Animal Pharmaceutical Dogs , by Region USD Million (2023-2028)
  • Table 199. Animal Pharmaceutical Horses , by Region USD Million (2023-2028)
  • Table 200. Animal Pharmaceutical Others , by Region USD Million (2023-2028)
  • Table 201. South America Animal Pharmaceutical, by Country USD Million (2023-2028)
  • Table 202. South America Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 203. South America Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 204. South America Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 205. South America Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 206. South America Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 207. Brazil Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 208. Brazil Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 209. Brazil Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 210. Brazil Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 211. Brazil Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 212. Argentina Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 213. Argentina Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 214. Argentina Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 215. Argentina Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 216. Argentina Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 217. Rest of South America Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 218. Rest of South America Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 219. Rest of South America Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 220. Rest of South America Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 221. Rest of South America Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 222. Asia Pacific Animal Pharmaceutical, by Country USD Million (2023-2028)
  • Table 223. Asia Pacific Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 224. Asia Pacific Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 225. Asia Pacific Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 226. Asia Pacific Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 227. Asia Pacific Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 228. China Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 229. China Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 230. China Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 231. China Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 232. China Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 233. Japan Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 234. Japan Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 235. Japan Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 236. Japan Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 237. Japan Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 238. India Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 239. India Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 240. India Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 241. India Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 242. India Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 243. South Korea Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 244. South Korea Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 245. South Korea Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 246. South Korea Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 247. South Korea Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 248. Taiwan Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 249. Taiwan Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 250. Taiwan Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 251. Taiwan Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 252. Taiwan Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 253. Australia Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 254. Australia Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 255. Australia Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 256. Australia Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 257. Australia Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 258. Rest of Asia-Pacific Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 259. Rest of Asia-Pacific Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 260. Rest of Asia-Pacific Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 261. Rest of Asia-Pacific Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 262. Rest of Asia-Pacific Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 263. Europe Animal Pharmaceutical, by Country USD Million (2023-2028)
  • Table 264. Europe Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 265. Europe Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 266. Europe Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 267. Europe Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 268. Europe Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 269. Germany Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 270. Germany Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 271. Germany Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 272. Germany Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 273. Germany Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 274. France Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 275. France Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 276. France Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 277. France Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 278. France Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 279. Italy Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 280. Italy Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 281. Italy Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 282. Italy Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 283. Italy Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 284. United Kingdom Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 285. United Kingdom Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 286. United Kingdom Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 287. United Kingdom Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 288. United Kingdom Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 289. Netherlands Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 290. Netherlands Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 291. Netherlands Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 292. Netherlands Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 293. Netherlands Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 294. Rest of Europe Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 295. Rest of Europe Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 296. Rest of Europe Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 297. Rest of Europe Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 298. Rest of Europe Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 299. MEA Animal Pharmaceutical, by Country USD Million (2023-2028)
  • Table 300. MEA Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 301. MEA Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 302. MEA Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 303. MEA Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 304. MEA Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 305. Middle East Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 306. Middle East Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 307. Middle East Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 308. Middle East Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 309. Middle East Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 310. Africa Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 311. Africa Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 312. Africa Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 313. Africa Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 314. Africa Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 315. North America Animal Pharmaceutical, by Country USD Million (2023-2028)
  • Table 316. North America Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 317. North America Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 318. North America Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 319. North America Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 320. North America Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 321. United States Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 322. United States Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 323. United States Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 324. United States Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 325. United States Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 326. Canada Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 327. Canada Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 328. Canada Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 329. Canada Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 330. Canada Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 331. Mexico Animal Pharmaceutical, by Type USD Million (2023-2028)
  • Table 332. Mexico Animal Pharmaceutical, by Application USD Million (2023-2028)
  • Table 333. Mexico Animal Pharmaceutical, by Disease USD Million (2023-2028)
  • Table 334. Mexico Animal Pharmaceutical, by Distribution Channel USD Million (2023-2028)
  • Table 335. Mexico Animal Pharmaceutical, by Animal USD Million (2023-2028)
  • Table 336. Animal Pharmaceutical: by Type(USD/Units)
  • Table 337. Research Programs/Design for This Report
  • Table 338. Key Data Information from Secondary Sources
  • Table 339. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Pharmaceutical: by Type USD Million (2017-2022)
  • Figure 5. Global Animal Pharmaceutical: by Application USD Million (2017-2022)
  • Figure 6. Global Animal Pharmaceutical: by Disease USD Million (2017-2022)
  • Figure 7. Global Animal Pharmaceutical: by Distribution Channel USD Million (2017-2022)
  • Figure 8. Global Animal Pharmaceutical: by Animal USD Million (2017-2022)
  • Figure 9. South America Animal Pharmaceutical Share (%), by Country
  • Figure 10. Asia Pacific Animal Pharmaceutical Share (%), by Country
  • Figure 11. Europe Animal Pharmaceutical Share (%), by Country
  • Figure 12. MEA Animal Pharmaceutical Share (%), by Country
  • Figure 13. North America Animal Pharmaceutical Share (%), by Country
  • Figure 14. Global Animal Pharmaceutical: by Type USD/Units (2017-2022)
  • Figure 15. Global Animal Pharmaceutical share by Players 2022 (%)
  • Figure 16. Global Animal Pharmaceutical share by Players (Top 3) 2022(%)
  • Figure 17. Global Animal Pharmaceutical share by Players (Top 5) 2022(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Zoetis, Inc. (United States) Revenue: by Geography 2022
  • Figure 21. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Bayer AG (Germany) Revenue: by Geography 2022
  • Figure 23. Boehringer Ingelheim GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Boehringer Ingelheim GmbH (Germany) Revenue: by Geography 2022
  • Figure 25. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 26. Eli Lilly and Company (United States) Revenue: by Geography 2022
  • Figure 27. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Merck & Co., Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Vetoquinol (France) Revenue, Net Income and Gross profit
  • Figure 30. Vetoquinol (France) Revenue: by Geography 2022
  • Figure 31. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 32. Virbac (France) Revenue: by Geography 2022
  • Figure 33. Ceva Sante Animale (France) Revenue, Net Income and Gross profit
  • Figure 34. Ceva Sante Animale (France) Revenue: by Geography 2022
  • Figure 35. Aratana Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Aratana Therapeutics, Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Other Revenue, Net Income and Gross profit
  • Figure 38. Other Revenue: by Geography 2022
  • Figure 39. Global Animal Pharmaceutical: by Type USD Million (2023-2028)
  • Figure 40. Global Animal Pharmaceutical: by Application USD Million (2023-2028)
  • Figure 41. Global Animal Pharmaceutical: by Disease USD Million (2023-2028)
  • Figure 42. Global Animal Pharmaceutical: by Distribution Channel USD Million (2023-2028)
  • Figure 43. Global Animal Pharmaceutical: by Animal USD Million (2023-2028)
  • Figure 44. South America Animal Pharmaceutical Share (%), by Country
  • Figure 45. Asia Pacific Animal Pharmaceutical Share (%), by Country
  • Figure 46. Europe Animal Pharmaceutical Share (%), by Country
  • Figure 47. MEA Animal Pharmaceutical Share (%), by Country
  • Figure 48. North America Animal Pharmaceutical Share (%), by Country
  • Figure 49. Global Animal Pharmaceutical: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Zoetis, Inc. (United States)
  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Eli Lilly and Company (United States)
  • Merck & Co., Inc. (United States)
  • Vetoquinol (France)
  • Virbac (France)
  • Ceva Sante Animale (France)
  • Aratana Therapeutics, Inc. (United States)
  • Other
Additional players considered in the study are as follows:
Dechra Pharmaceuticals plc (United Kingdom)
Select User Access Type

Key Highlights of Report


Jul 2023 218 Pages 95 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and Asia Animal Pharmaceutical Market Quantitative research analysis
Global and Asia Animal Pharmaceutical Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Animal Pharmaceutical market are Zoetis, Inc. (United States), Bayer AG (Germany), Boehringer Ingelheim GmbH (Germany), Eli Lilly and Company (United States), Merck & Co., Inc. (United States), Vetoquinol (France), Virbac (France), Ceva Sante Animale (France), Aratana Therapeutics, Inc. (United States) and Other, to name a few.
"Increasing Pet Ownership " is seen as one of major influencing trends for Animal Pharmaceutical Market during projected period 2022-2028.
Vaccines segment in Global market to hold robust market share owing to "Increasing prevalence of zoonotic diseases ".

Know More About Global and Asia Animal Pharmaceutical Market Report?

Have a Query? Click Here

Other Related Reports

Creatine Kinase Comprehensive Study by Type (Kits & Reagents, Instruments), End-users (Hospitals, Clinics, Diagnostic Laboratories, Academic Research Institutes), Test Type (Colorimetric Assay Based ...
$ 3450
Methadone Comprehensive Study by Type (Oral Medicine (Tablets, Liquid), Injections), Application (Operation, Detoxification, Others) Players and Region - Global Market Outlook to 2026
$ 3500
Human Endostatin Comprehensive Study by Type (Idiopathic, Paraneoplastic), Application (Medical Care, Scientific Research, Others), Distribution Channel (Direct, Indirect) Players and Region - Global...
$ 3500
MRSA Antibiotics Comprehensive Study by Type (Vancomycin, Teicoplanin, Linezolid, Cubicin, Others), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmac...
$ 3350
Inulin Comprehensive Study by Application (Granola Bars, Frozen Desserts, Nutritional Beverage Powders, Beverages, Others), Industry Verticals (Food and Beverages, Pharmaceuticals, Others), Sales Cha...
$ 3450
Life Science Reagents Comprehensive Study by Type (Chromatography Reagents, In-vitro Diagnostics Reagents, Polymerase Chain Reaction Reagent Kits, Others), Application (Pharmaceutical, Biotechnology,...
$ 3800